Factor VII deficiency
MONDO:0002244A coagulation disorder characterized by the partial or complete absence of factor VII activity in the blood.
Also known as: F7 deficiency, deficiency, stable, factor 7 deficiency, factor VII deficiency
17 clinical trials for this condition and its sub-types, 6 tagged with Factor VII deficiency itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Factor VII deficiency
-
Congenital factor VII deficiency 3 trials
-
Acquired factor VII deficiency 0 trials
-
New shot could tame rare bleeding disorder
Disease control Recruiting nowThis study tests a new drug called sutacimig in 18 adults with a rare inherited bleeding disorder (factor VII deficiency). The drug is given as a single shot under the skin to see if it is safe and can help prevent bleeding. The goal is to find a more convenient treatment option …
Phase 2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New hemophilia drug enters human safety trials
Disease control Recruiting nowThis early-stage study tests a new drug called SR604 in healthy people and those with hemophilia A, B, or factor VII deficiency. The main goal is to check safety and how the drug moves through the body. About 31 participants will receive single or multiple doses to find the right…
Phase 1 • Sponsor: Equilibra Bioscience LLC • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New shot aims to cut bleeding in hemophilia patients
Disease control Recruiting nowThis study tests an experimental injection called SR604 in 76 adults with hemophilia A, B, or congenital factor VII deficiency. The goal is to see if it is safe and can reduce bleeding episodes. Participants will receive either a single dose or multiple doses, and researchers wil…
Phase 1/2 • Sponsor: Shanghai RAAS Blood Products Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC